Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Dae Ryong Cha Ki Ryang Na |
| Publication date | September 6, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |